Press Digest
Press digest - year 2025
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2024.
Source: BSE (31.01.2025)
 
Sopharma AD reports a decline in unconsolidated profit by BGN 17.5 million, or nearly a third, to BGN 30.1 million for 2024. Sales decrease by BGN 21 million, or 7%, to BGN 265.5 million. Sales of products are down by 6.5% to BGN 235 million. The main foreign markets are Russia, Ukraine, Belarus, Poland, the countries of the former Yugoslavia, Georgia, Armenia, Kazakhstan. Bulgaria has a share of about one third. The consolidated report is important for Sopharma, as in the absence of progress in the production of medicines, the company has found other niches. The subsidiary Sopharma Trading has over BGN 1 billion. turnover from drug sales, the subsidiary "Sopharma Imoti" REIT (in which "Sopharma" has a 46% share) rents out office space, the subsidiary "Sopharma Buildings" REIT is building buildings in Sofia (on the site of the former "Unipharm" in the Darvenitsa district), and "Dover United Holding" AD (23% share of "Sopharma") has a bank in Moldova and holds the franchise of "Monsieur Bricolage" for Bulgaria.
Source: investor.bg (03.02.2025)
 
The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 2 at its session held on 10 March 2025: I. With reference to item 12 of Appendix No. 1 (SOFIX Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising SOFIX in effect from 24 March 2025: BSE code Issuer Free-float factor ATER Advance Terrafund REIT 0.6100 BSE Bulgarian Stock Exchange AD 0.4995 DUH Doverie United Holding PLC 0.6018 EUBG Eurohold Bulgaria AD 0.4710 SGH Sirma Group Holding AD 0.5988 SO Smart Organic AD 0.1485 SFA Sopharma AD 0.2726 FIB CB First Investment Bank AD 0.1107 CCB CB Central Cooperative Bank AD 0.1666 TIB Telematic Interactive Bulgaria AD 0.0955 WISR Wiser Technology AD 0.4774 BREF Bulgarian Real Estate Fund REIT 0.7428 CHIM Chimimport AD 0.2159 HVAR Holding Varna AD 0.3183 SLYG Shelly Group SE 0.3036 The free-float data on the issues of SOFIX presented herein are the median values for the period 02 December 2024 - 01 March 2025. II. With reference to item 11 of Appendix No. 2 (BGBX 40 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BGBX 40 in effect from 24 March 2025: BSE code Issuer Free-float factor AGH Agria Group Holding AD 0.2119 ATER Advance Terrafund REIT 0.6100 ALB Albena AD 0.2993 BPF Bravo Property Fund REIT 0.1671 BMTL Bulmetal AD 0.2343 BSE Bulgarian Stock Exchange AD 0.4995 GR6 Gradus AD 0.1788 DUH Doverie United Holding PLC 0.6018 EUBG Eurohold Bulgaria AD 0.4710 EAC Elana Agrocredit AD 0.6650 EMKA EMKA AD 0.2268 ZHBG Zarneni Hrani Bulgaria AD 0.2001 11C Eleven Capital AD 0.5510 HIKA Industrial Capital Holding AD 0.5662 KBG Korado-Bulgaria AD 0.1785 MSH M+S Hydraulic AD 0.2295 MONB Monbat AD 0.1724 NEOH Neochim AD 0.3139 PET Petrol AD 0.0570 SNRG Synergon Holding AD 0.4204 SGH Sirma Group Holding AD 0.5988 SO Smart Organic AD 0.1485 SFA Sopharma AD 0.2726 SFB Sopharma Buildings REIT 0.2695 SFI Sopharma Properties REIT 0.0901 SFT Sopharma Trading AD 0.1201 SCOM Sofia Commerce-Pawn Brokerage AD 0.3378 SPDY Speedy AD 0.1010 SPH Stara Planina Hold AD 0.5935 FIB CB First Investment Bank AD 0.1107 CCB CB Central Cooperative Bank AD 0.1666 TBS Telelink Business Services Group AD 0.1304 TIB Telematic Interactive Bulgaria AD 0.0955 T57 Trace Group Hold AD 0.1877 WISR Wiser Technology AD 0.4774 BREF Bulgarian Real Estate Fund REIT 0.7428 HES Hydraulic Elements and Systems /HES/ AD 0.2029 CHIM Chimimport AD 0.2159 HVAR Holding Varna AD 0.3183 SLYG Shelly Group SE 0.3036 The free-float data on the issues of BGBX 40 presented herein are the median values for the period 02 December 2024 - 01 March 2025.
Source: BSE (11.03.2025)
 
The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 2 at its session held on 10 March 2025: III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 24 March 2025: BSE code Issuer Free-float factor ATER Advance Terrafund REIT 0.6100 BSP Balkan and Sea Properties REIT 0.4126 CCBR Grand Vision Properties REIT 0.5092 RPF Roi Property Fund REIT 0.4088 SFB Sopharma Buildings REIT 0.2695 SBPF Super Borovetz Property Fund REIT 0.5465 BREF Bulgarian Real Estate Fund REIT 0.7428 The free-float data on the issues of BG REIT presented herein are the median values for the period 02 December 2024 - 01 March 2025. IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 24 March 2025: BSE code Issuer Free-float factor ITF ITF Group AD 0.1148 BDT Biodit AD 0.1719 BLRN Boleron AD 0.2145 DRON Dronamics Capital AD 0.9400 HRC HR Capital JSC 0.1805 IMP ImPulse Growth AD 0.8507 IPSP IpoTech Sofcom AD 0.6219 PAY Paysera Bulgaria JSC 0.1627 SIN Sin Cars Industry AD 0.1228 WIN Webit Investment Network AD 0.8556 The free-float data on the issues of beamX presented herein are the median values for the period 02 December 2024 - 01 March 2025. V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 21 March 2025. VI. The next session of the Indices Committee, at which free-float factors of the issues comprising the BSE Indices (including beamX) are to be specified, shall be held on 02 June 2025, as these are to enter into force as of 23 June 2025.
Source: BSE (11.03.2025)
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT publishes Annual Financial Report for the activities of special purpose entities – ESEF format as of 31-12-2024.
Source: BSE (26.03.2025)
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT presented quarterly report for the first quarter of 2025.
Source: BSE (02.05.2025)
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT convenes a regular General Meeting of Shareholders on 26.06.2025 at 11:00 a.m. in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers, Building A, floor 20, with the following agenda: - Report of the management bodies on the company's activities in 2024; - Adoption of the company's annual financial statements for 2024; - Report of the registered auditor for 2024; - Report of the Audit Committee for 2024; - Report of the Investor Relations Director for 2024; - Adoption of a report on the implementation of the Remuneration Policy for the members of the management bodies; - Discharge of the members of the management bodies from liability for their activities in 2024; - Election of a registered auditor for 2025; - Adoption of a new Statute of the Audit Committee; - Decision on the distribution of financial results. Draft decision: Does not distribute a dividend since the company ended 2024 with a negative financial result in the amount of BGN 91,693.58. Adopts a decision that the formed loss will be covered by the accumulated reserves from the Reserve Fund; - Changes in the management bodies of the company. Draft decision: Re-elects the members of the Board of Directors Irina Mincheva, Emil Kostov and Stoycho Pangev, for a new term of 5 years; - Determination of the amount of the remuneration of the members of the management bodies. - Determination of the amount of the management guarantee for the members of the management bodies. - Adoption of a decision under Art. 244, para. 7, s. 2 of the Commercial Act to authorize a person to conclude, on behalf and for the account of the company, contracts for the assignment of management with the members of the Board of Directors. - In the absence of a quorum, the meeting will be held on 11.07.2025 at 11:00 a.m. at the same place and with the same agenda. The right to vote in the General Meeting of Shareholders is exercised by the persons registered as such with the right to vote in the central securities register 14 days before the date of the General Meeting of Shareholders, or as of 12.06.2025. The last date for concluding transactions with shares of this company on the Exchange, as a result of which the acquirer will be able to exercise the right to vote in the General Meeting of Shareholders, is 10.06.2025.
Source: BSE (22.05.2025)
 
The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 4 at its session held on 02 June 2025: III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 23 June 2025: BSE code Issuer Free-float factor ATER Advance Terrafund REIT 0.6091 BSP Balkan and Sea Properties REIT 0.4112 CCBR Grand Vision Properties REIT 0.5094 RPF Roi Property Fund REIT 0.4089 SFB Sopharma Buildings REIT 0.2697 SBPF Super Borovetz Property Fund REIT 0.5464 BREF Bulgarian Real Estate Fund REIT 0.7428 The free-float data on the issues of BG REIT presented herein are the median values for the period 02 March 2025 - 01 June 2025. IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 23 June 2025: BSE code Issuer Free-float factor BDT Biodit AD 0.1706 BLRN Boleron AD 0.2146 DRON Dronamics Capital AD 0.9400 HRC HR Capital JSC 0.1805 IMP ImPulse Growth AD 0.8487 IPSP IpoTech Sofcom AD 0.6219 ITF ITF Group AD 0.1148 PAY Paysera Bulgaria JSC 0.1627 SIN Sin Cars Industry AD 0.1228 WIN Webit Investment Network AD 0.8607 The free-float data on the issues of beamX presented herein are the median values for the period 02 March 2025 - 01 June 2025. V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 20 June 2025. VI. The next session of the Indices Committee, at which free-float factors of the issues comprising the BSE Indices (including beamX) are to be specified, shall be held on 02 September 2025, as these are to enter into force as of 23 September 2025.
Source: BSE (03.06.2025)
 
Sopharma Buildings REIT (SFB) Information on the decisions taken by the regular GMS held on 26 June 2025
Source: BSE (27.06.2025)
 
Sopharma Buildings REIT (SFB) The regular General Meeting of Shareholders of Sopharma Buildings REIT, dated 26 June 2025, passed the following resolutions: - Adoption of the 2024 activity report of the managing bodies - Adoption of the 2024 annual financial report of the company - Adoption of the report of the registered auditor on the verification of the 2024 annual financial report - Adoption of the report of the Audit Committee for 2024 - Adoption of the report of the Investor Relations Director for 2024 - Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies - Release from liability of the members of the managing bodies for their activity in 2024 - Election of a registered auditor for 2025 - Adoption of a new statute of the Audit Committee - No dividend distribution for 2024 due to realised loss of BGN 91,693.58, but covering the loss by funds of the company's accumulated reserves - Re-election of Irina Mincheva, Emil Kostov and Stoycho Pangev as members of the Board of Directors with a new 5-year mandate - Determination of the remuneration to the members of the managing bodies - Determination of the guarantee for the management of the members of the managing bodies - Authorisation of Irina Mincheva to sign the management agreements with the members of the Board of Directors on behalf and for the account of the company
Source: BSE (30.06.2025)
 
Sopharma Buildings REIT (SFB) Insider information under Art. 17 (1) in conjunction with Art. 7 of Regulation (EU) No. 596/2014 of the EP and the Council
Source: BSE (15.07.2025)
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT presented its quarterly report for the second quarter of 2025.
Source: BSE (31.07.2025)
 
BSE Board of Directors adopted the following decisions under Record of Proceedings No. 70 of 09 September 2025: II. Revision of the BGBX 40 index base According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 15 of Appendix No. 2 (BGBX 40 Calculation Methodology), the BSE Board of Directors excluded the following three issues of shares from the BGBX 40 index base: HIKA Industrial Capital Holding AD, SNRG Synergon Holding AD, and SFB Sopharma Buildings REIT; And included the following four issues of shares in the BGBX 40 index base: THQM Tchaikapharma High Quality Medicines AD, HSI Sila Holding AD, and ALCM Alcomet AD. III. Revision of the BG REIT index base According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 12 of Appendix No. 3 (BG REIT Calculation Methodology), the BSE Board of Directors excluded the following issue of shares from the BG REIT index base: SFB Sopharma Buildings REIT; And included the following issue of shares in the BG REIT index base: CITP Premium Property Invest REIT. IV. Revision of the BG TR30 index base According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 17 of Appendix No. 4 (BG TR30 Calculation Methodology), the BSE Board of Directors excluded the following five issues of shares from the BG TR30 index base: GR6 Gradus AD, CAPM Capital Management SPV, NEOH Neochim AD, SPDY Speedy AD, and SBPF Super Borovetz Property Fund REIT; And included the following five issues of shares in the BG TR30 index base: HSI Sila Holding AD, TXIM CB Texim Bank AD, TIB Telematic Interactive Bulgaria AD, TCH TK-Hold PLC, and HNVK Holding Nov Vek AD. V. Revision of the beamX index base According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 20 of the Rules for Calculating the beam Market Companies' Index (beamX), the BSE Board of Directors excluded the following issue of shares from the beamX index base: IPSP IpoTech Sofcom AD, And included the following issue of shares in the beamX index base: GGS Global Gaming Solutions AD. The amendments to the above index bases will become effective on 23 September 2025.
Source: BSE (10.09.2025)
 
Sopharma Buildings REIT (SFB) Sopharma Buildings REIT presented its quarterly report for the Third Quarter of 2025.
Source: BSE (31.10.2025)